138 related articles for article (PubMed ID: 36893818)
21. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
Backes FJ; Felix AS; Plante M; Grégoire J; Sullivan SA; Rossi EC; Tanner EJ; Stewart KI; Soliman PT; Holloway RW; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2021 May; 161(2):347-352. PubMed ID: 33678480
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
Son J; Chambers LM; Carr C; Michener CM; Yao M; Beavis A; Yen TT; Stone RL; Wethington SL; Fader AN; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan A; Ricci S
Int J Gynecol Cancer; 2020 Nov; 30(11):1738-1747. PubMed ID: 32771986
[TBL] [Abstract][Full Text] [Related]
24. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
Yarandi F; Shirali E; Akhavan S; Nili F; Ramhormozian S
Eur J Med Res; 2023 Mar; 28(1):118. PubMed ID: 36915143
[TBL] [Abstract][Full Text] [Related]
25. Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
Peters EEM; Léon-Castillo A; Hogdall E; Boennelycke M; Smit VTHBM; Hogdall C; Creutzberg CL; Bosse T; Nout RA; Ørtoft G
Int J Gynecol Pathol; 2022 May; 41(3):227-234. PubMed ID: 34392268
[TBL] [Abstract][Full Text] [Related]
26. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
[TBL] [Abstract][Full Text] [Related]
27. Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival.
Lee SJ; Kang HJ; Kwak YK; Kim M; Kim J
Strahlenther Onkol; 2023 Sep; 199(9):828-837. PubMed ID: 36930247
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of three-tiered scoring system for lymph-vascular space invasion in endometrial cancer: A systematic review and meta-analysis.
Han L; Chen Y; Zheng A; Tan X; Chen H
Gynecol Oncol; 2024 Feb; 184():198-205. PubMed ID: 38335803
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
30. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
[TBL] [Abstract][Full Text] [Related]
31. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
32. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.
Ørtoft G; Lausten-Thomsen L; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2019 Sep; 30(5):e84. PubMed ID: 31328462
[TBL] [Abstract][Full Text] [Related]
33. Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer.
Peters EEM; León-Castillo A; Smit VTHBM; Boennelycke M; Hogdall E; Hogdall C; Creutzberg C; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JWM; Lutgens LCHW; van der Steen-Banasik EM; Ortoft G; Bosse T; Nout R
Int J Gynecol Pathol; 2022 May; 41(3):220-226. PubMed ID: 34261899
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of stage II endometrial cancer: The UPMC Hillman Cancer Center experience.
Chen KS; Berhane H; Gill BS; Olawaiye A; Sukumvanich P; Kelley JL; Boisen MM; Courtney-Brooks M; Comerci JT; Edwards R; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):315-319. PubMed ID: 28866431
[TBL] [Abstract][Full Text] [Related]
35. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
Weinberg LE; Kunos CA; Zanotti KM
Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
[TBL] [Abstract][Full Text] [Related]
36. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.
Ronsini C; Anchora LP; Restaino S; Fedele C; Arciuolo D; Teodorico E; Bizzarri N; Zannoni GF; Ferrandina G; Scambia G; Fanfani F
Gynecol Oncol; 2021 Aug; 162(2):299-307. PubMed ID: 34116834
[TBL] [Abstract][Full Text] [Related]
37. Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer.
Algan O; Tabesh T; Hanlon A; Hogan WM; Boente M; Lanciano RM
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):925-33. PubMed ID: 8751401
[TBL] [Abstract][Full Text] [Related]
38. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
39. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
[TBL] [Abstract][Full Text] [Related]
40. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
